DJIA 16,912.29 122.10 0.73%
NASDAQ 4,791.15 42.79 0.90%
S&P 500 1,995.83 15.91 0.80%
market minute promo

Ophthotech (NASDAQ: OPHT)

42.25 2.36 (5.92%)

Quote as of

Extended Hours: $42.25 $0.00 (0.00%)
Quote as of (NASDAQ)

company name or ticker

Recent Quotes

OPHT $42.25 5.92%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $39.69
Previous Close $39.89
Daily Range $38.55 - $42.76
52-Week Range $35.72 - $72.51
Market Cap $1.5B
P/E Ratio -40.29
Dividend (Yield) $0.00 (0.0%)
Volume 352,570
Average Daily Volume 484,538
Current FY EPS -$3.10



Ophthotech (OPHT) Description

Ophthotech Corp is a biopharmaceutical company specializing in the development of novel therapeutics to treat diseases of the back of the eye with a focus on developing therapeutics for age-related macular degeneration. Website:

News & Commentary

3 Speculative Growth Stocks That Might Be Worth the Risk

Looking for a few growth stocks that could power your portfolio higher? Our contributors think these 3 names deserve a look.

3 Biotechs That Play Well with Others

Kindergarten teachers would be proud -- instead of battling to beat out their competitors, these companies are relying on a cooperative strategy that could benefit everyone involved -- including investors.

Relative Strength Alert For Ophthotech

Battleground: Will This $5 Biotech Stock Go To $22 Or $1.50?

Commit To Purchase Ophthotech Corp At $50, Earn 29.2% Annualized Using Options

What's Behind Ophthotech's Rapid Run Higher in July?

A chance for its clinical-stage drug Fovista to become a go-to vision therapy is sending shares higher.

Will Ophthotech (OPHT) Continue to Surge Higher? - Tale of the Tape

3 Tiny Stocks to Buy If Biotech Tumbles

Ophthotech Corp., Portola Pharmaceuticals, and Amicus Therapeutics could be buys if biotech stocks fall.

Ophthotech (OPHT) is Overbought: Is A Drop Coming? - Tale of the Tape

5 Drugs That Investors May Be Undervaluing

One Foolish investor thinks these five drugs could send shares in these companies higher.

See More OPHT News...